JDD Highlights
The August issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Psoriasis, with special features on Public Health, Anti-aging, Aesthetic, and Medical Dermatology.
Read the JDD Now
Psoriasis, Public Health, Anti-Aging, Aesthetic, and Medical Dermatology
The August issue of the Journal of Drugs in Dermatology is available now. This month, we focus on psoriasis with special features on Public Health, Anti-aging, Aesthetic, and Medical Dermatology.
Article Highlights
- Clearance of psoriasis leads to greater uptake of cosmetic procedures in Increased Trend of Cosmetic Procedures in Patients With Psoriasis Who Attain 75% or Greater Improvement
- The Effect of Tildrakizumab on Cardiometabolic Two Phase 3 Trials (reSURFACE 1 and reSURFACE 2) examines the impact of IL-23 inhibition on cardiometabolic risk factors in patients with moderate to severe psoriasis.
- Metformin demonstrates promising clinical response and favorable safety profile for treatment in Oral Metformin for Treating Dermatological Diseases: A Systematic Review
- Fixed Combination Cal/BD Foam for Beyond-Mild Psoriasis: A Possible Alternative to Systemic Medication demonstrated favorable outcomes in patients with greater-than-mild psoriasis severity
- Safety and efficacy of treatment of chronic plaque psoriasis is assessed in Roflumilast Cream Improves Signs and Symptoms of Plaque Psoriasis: Results from a Phase 1/2a Randomized, Controlled Study
- A post-hoc analysis evaluates efficacy in Nail Psoriasis Does Not Affect Skin Response to Ixekizumab in Patients With Moderate-to-Severe Psoriasis
Editor's Picks
- Promotion: The State of Sunscreens in the US: Caveat Emptor Increased Trend of Cosmetic Procedures in Patients With Psoriasis Who Attain 75% or Greater Improvement Cutaneous Langerhans Cell Histiocytosis Responsive to Topical Nitrogen Mustard
- Consensus about the Importance of Ceramide Containing Skincare for Normal and Sensitive Skin Conditions in Neonates and Infants
- Topical Cannabinoids for the Management of Psoriasis Vulgaris: Report of a Case and Review of the Literature
- Aesthetics: Increased Trend of Cosmetic Procedures in Patients With Psoriasis Who Attain 75% or Greater Improvement
You May Also Like
Dermatology Roundup: Newly FDA-Approved Cheek Filler, Molluscrum Contagiosum Trial Results, Eating Disorders & Acne Vulgaris
By Allison Sit The Food and Drug Administration has approved Restylane Contour for cheek augmentation and correction of midface contour deficiencies in adults older than 21. Approval of the new…
